Joby Aviation, Inc., JOBYThe transaction structure includes $450 million in cash consideration plus $50 million worth of Joby shares. Resonant Sciences specializes in designing, producing, and supplying sophisticated radio-frequency and mission systems to U.S. national security agencies. Kirby preserved his Underweight (Sell) recommendation and $7 price objective for JOBY, commenting “the current progress is fully baked in.” The mean price objective of $13.13 suggests approximately 49% appreciation potential within the next twelve months. The Resonant Sciences transaction requires regulatory clearance and is projected to finalize during early 2027.